Metropolis Healthcare Ltd., a leading diagnostic service provider, today announced its audited consolidated financial results today for the first quarter. They have recorded a growth revenue of INR 327 crore in Q1FY22.
Below are the key highlights of the results for your reference.
- Recorded highest ever quarterly patient visits at 3.5 Mn & number of tests at 6.5 Mn
- Patient visits grew by 11% and number of tests grew by 1% on QoQ basis
- Revenue from home visits business increased by 19% QoQ to Rs. 37 Crores in Q1FY22
“We take immense pleasure in announcing that we have successfully continued from our last quarter and have delivered our highest ever quarterly revenue supplemented strongly, by both our COVID and non-COVID revenues. Metropolis Healthcare Ltd. continues to work and support our government and healthcare fraternity in the fight against COVID-19, even as we march on in our tireless efforts to grow exponentially as a brand, provide incremental value to our shareholders, and the best in quality to our customers. Digital transformation remains focal for us, in our relentless pursuit of world-class customer experience. We always have, and will continue to, prioritize safety, quality, and hygiene.
While the pandemic still lurks over our shoulder, we have seen a strong acceptance to brand Metropolis which is visible in our growth across the board.” – Ameera Shah, Promoter and Managing Director, Metropolis Healthcare Ltd. MB Bureau